PeptideDB

LSD1-IN-30 1289575-45-6

LSD1-IN-30 1289575-45-6

CAS No.: 1289575-45-6

LSD1-IN-30 (compound 3) is a potent inhibitor of lysine-specific demethylase 1 (LSD1) with IC50 of 0.291 μM.
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

LSD1-IN-30 (compound 3) is a potent inhibitor of lysine-specific demethylase 1 (LSD1) with IC50 of 0.291 μM.

Physicochemical Properties


Molecular Formula C15H14N2O3
Molecular Weight 270.283263683319
Exact Mass 270.1
CAS # 1289575-45-6
PubChem CID 135442596
Appearance Off-white to yellow solid powder
LogP 2.3
Hydrogen Bond Donor Count 3
Hydrogen Bond Acceptor Count 4
Rotatable Bond Count 3
Heavy Atom Count 20
Complexity 362
Defined Atom Stereocenter Count 0
SMILES

C/C(=N\NC(=O)C1=CC=C(C=C1)O)/C2=CC=CC=C2O

InChi Key LVGDDYSLMCRYJE-MHWRWJLKSA-N
InChi Code

InChI=1S/C15H14N2O3/c1-10(13-4-2-3-5-14(13)19)16-17-15(20)11-6-8-12(18)9-7-11/h2-9,18-19H,1H3,(H,17,20)/b16-10+
Chemical Name

4-hydroxy-N-[(E)-1-(2-hydroxyphenyl)ethylideneamino]benzamide
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


Targets LSD1 0.291 μM (IC50)
References

[1].High-Throughput Virtual Screening Identifies Novel N′‑(1-Phenylethylidene)-benzohydrazides as Potent, Specific, and Reversible LSD1 Inhibitors. J Med Chem . 2013 Dec 12;56(23):9496-508.


Solubility Data


Solubility (In Vitro) DMSO :~100 mg/mL (~369.99 mM; with sonication)
Solubility (In Vivo) Solubility in Formulation 1: 2.5 mg/mL (9.25 mM) in 10% DMSO + 40% PEG300 + 5% Tween-80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one),clear solution; with ultrasonication.
For example, if 1 mL of working solution is to be prepared,you can add 100 μL of 25.0 mg/mL clear DMSO stock solution and add it to 400 μL PEG300 and mix well. Then add 50 μL Tween-80 to the above system and mix well. Then continue to add 450 μL of physiological saline to make up to 1 mL.
Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution.

Solubility in Formulation 2: 2.5 mg/mL (9.25 mM) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one),clear solution; with ultrasonication.
For example, if 1 mL of working solution is to be prepared,you can add 100 μL of 25.0 mg/mL clear DMSO stock solution and add it to 900 μL corn oil and mix well.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 3.6999 mL 18.4993 mL 36.9987 mL
5 mM 0.7400 mL 3.6999 mL 7.3997 mL
10 mM 0.3700 mL 1.8499 mL 3.6999 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.